{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":2125,"total_is_capped":false,"direct_labels_cover":7,"predictions_cover":2125,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"3b29752edd81","filters":{"topic":"Hepatocellular Carcinoma Treatment and Prognosis"}},"results":[{"id":"W2163403599","doi":"10.1002/hep.24199","title":"Management of Hepatocellular Carcinoma: An Update Δσ","year":2011,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":8133,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Hepatitis B virus; Liver cancer; Hepatology; Guideline; Hepatitis B; Internal medicine; Liver biopsy; Hepatitis; Biopsy; Gastroenterology; Pathology; Virus; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.09014841183870012,"gpt":0.2568109597063466,"spread":0.1666625478676465,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001637722,0.0002254728,0.0005112586,0.0001690619,0.00006387533,0.000004882768,0.0001539984,0.0001666418,0.001150798],"category_scores_gemma":[0.000003664123,0.0002001363,0.0001736046,0.0002125352,0.0001839765,0.00007881327,0.00007612196,0.0001209545,0.0002072714],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003880615,"about_ca_system_score_gemma":0.00006423938,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003018402,"about_ca_topic_score_gemma":0.0000104802,"domain_scores_codex":[0.9985324,0.00009572279,0.0004078738,0.0003989233,0.0001814103,0.000383728],"domain_scores_gemma":[0.9989222,0.00001128884,0.0001150938,0.0006409078,0.00008897538,0.0002214905],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002633299,0.0005769688,0.981534,0.0001926963,0.000220104,0.003714847,0.0004245092,7.04341e-9,0.0003336665,0.008387608,0.0001309993,0.004221238],"study_design_scores_gemma":[0.009871892,0.004605175,0.7088581,0.0001801627,0.003362792,0.001703767,0.0008254362,0.02065237,0.2194987,0.004351435,0.02492408,0.001166009],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9822882,0.0009315755,0.000221954,0.0001187988,0.0001483379,0.0005241512,0.000008524705,0.00008867155,0.01566978],"genre_scores_gemma":[0.9924768,0.0001383897,0.006681852,0.0001664337,0.00003292223,0.00007074133,0.00009707236,0.00003729806,0.0002985571],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2726759,"threshold_uncertainty_score":0.9997623,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3025022288","doi":"10.1056/nejmoa1915745","title":"Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma","year":2020,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":7245,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Roche (Canada)","funders":"Bayer Yakuhin; Eli Lilly Japan; Chugai Pharmaceutical; Novartis Pharma; Genentech; Sirtex Medical; Ipsen; Dainippon Sumitomo Pharma; Yakult Honsha; Gilead Sciences; Servier; Advanced Accelerator Applications; Teijin Pharma; Otsuka Pharmaceutical; Eisai; BeiGene; Cisco Systems; F. Hoffmann-La Roche; Ipsen Biopharmaceuticals; Taiho Pharmaceutical; EA Pharma Co., Ltd.; Baxalta; Bayer HealthCare; Exelixis; Sanofi; Amgen; Pfizer; AstraZeneca; Ono Pharmaceutical; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Atezolizumab; Bevacizumab; Hepatocellular carcinoma; Medicine; Oncology; Internal medicine; Carcinoma; Cancer; Chemotherapy; Immunotherapy; Nivolumab","retraction":null,"screen_n_in":null,"score":{"opus":0.0791161146425367,"gpt":0.264622043496366,"spread":0.1855059288538293,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005996425,0.0002786477,0.001036088,0.0003204893,0.00004234904,0.00001289299,0.0001896134,0.0001258108,0.0007648121],"category_scores_gemma":[0.0004743882,0.0001910451,0.0001787575,0.0005730366,0.00008371042,0.0001368521,0.00003827989,0.0006188889,0.00003095136],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002035909,"about_ca_system_score_gemma":0.0006220617,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004297089,"about_ca_topic_score_gemma":0.00002365507,"domain_scores_codex":[0.9976178,0.0001465801,0.0008833923,0.000247738,0.0007151703,0.0003893134],"domain_scores_gemma":[0.9982477,0.0001548321,0.0002881589,0.0002071134,0.0001953767,0.0009068429],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.004748455,0.0001016047,0.9350603,0.0001659132,0.000151329,0.01250873,0.004112429,0.00001226357,0.005177457,0.00008930539,0.006024811,0.0318474],"study_design_scores_gemma":[0.6097218,0.02722044,0.09143737,0.002191978,0.002122857,0.01139712,0.001701429,0.02750975,0.02498042,0.0009206189,0.1998629,0.0009333241],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9600632,0.008668344,0.0003343683,0.02782355,0.0002700627,0.0003561795,0.00000221877,0.00002255965,0.002459535],"genre_scores_gemma":[0.9940333,0.0004207636,0.0004288817,0.001162433,0.00356936,0.000003195834,0.00001887682,0.00003774296,0.0003253839],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8436229,"threshold_uncertainty_score":0.8374156,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2163486683","doi":"10.1002/hep.20933","title":"Management of Hepatocellular Carcinoma *","year":2005,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":5881,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Guideline; Liver transplantation; MEDLINE; Hepatocellular carcinoma; Best practice; Systematic review; Percutaneous ethanol injection; Evidence-based medicine; Health care; Family medicine; Transplantation; Radiofrequency ablation; Surgery; Pathology; Alternative medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04696041663914593,"gpt":0.2559046005862045,"spread":0.2089441839470585,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001083441,0.0001694141,0.0004186313,0.0001347108,0.00003737807,0.000003226155,0.0000894016,0.0001260376,0.0006532218],"category_scores_gemma":[0.000004213967,0.000151116,0.0001856011,0.0001897458,0.00009141529,0.00004059987,0.00005576203,0.00009870694,0.0002862341],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006395467,"about_ca_system_score_gemma":0.00004473248,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004112452,"about_ca_topic_score_gemma":0.000003661401,"domain_scores_codex":[0.998848,0.00004423445,0.0003418845,0.0002772296,0.0001817086,0.0003069073],"domain_scores_gemma":[0.9993024,0.00002278726,0.00007968268,0.0003982927,0.00006419023,0.0001326764],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001070072,0.0002632731,0.974745,0.0001729528,0.0001742483,0.001056207,0.0000836748,9.049162e-8,0.0006121029,0.003780625,0.0005546969,0.01845009],"study_design_scores_gemma":[0.01148659,0.001797739,0.3401986,0.0002480246,0.002344498,0.001979856,0.000299048,0.07275522,0.268647,0.0006506793,0.2986634,0.0009293976],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9741269,0.002075064,0.0001527735,0.001303952,0.00007849211,0.000437114,0.000004552408,0.00006431706,0.02175681],"genre_scores_gemma":[0.9924272,0.0001782478,0.005620085,0.000227055,0.00007298821,0.0000541105,0.00003987584,0.00002470151,0.001355727],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6345465,"threshold_uncertainty_score":0.7152321,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4211183069","doi":"10.1038/nrdp.2016.18","title":"Hepatocellular carcinoma","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Disease Primers","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":2655,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Sorafenib; Oncology; Cancer; Internal medicine; Liver cancer; Ramucirumab; Liver transplantation; Hepatitis B virus; Disease; Transplantation; Immunology; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.08938072593381767,"gpt":0.3396463814310051,"spread":0.2502656554971874,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0005570968,0.001397895,0.005075589,0.0004704915,0.0001327606,0.00004914625,0.0004603715,0.001337248,0.001180441],"category_scores_gemma":[0.0003754572,0.0008092354,0.004801554,0.0007136753,0.0001357199,0.0001113685,0.0001566727,0.001504566,0.00404367],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005629192,"about_ca_system_score_gemma":0.00149212,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003187508,"about_ca_topic_score_gemma":1.24865e-7,"domain_scores_codex":[0.9951724,0.0006275253,0.001366273,0.001356903,0.0006678558,0.0008089984],"domain_scores_gemma":[0.995595,0.0001628636,0.0007152266,0.001859888,0.0001339973,0.001532985],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003756852,0.0001737665,0.008812788,0.05840826,0.0004849295,0.001195976,0.000005075434,1.408621e-10,4.427656e-7,0.0001140793,0.008072624,0.9226945],"study_design_scores_gemma":[0.0005536125,0.00007054741,0.0000764474,0.05261801,0.01322003,0.00008949317,6.046792e-7,0.000002867421,0.000003076404,0.00001770806,0.9325862,0.0007614021],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001766126,0.9894114,0.000009585453,0.0001972216,0.0005306597,0.007390379,0.0002046893,0.0001689261,0.002069439],"genre_scores_gemma":[0.00016375,0.9924833,0.0003537968,0.0004013536,0.0009171451,0.001243282,0.001364351,0.000250689,0.002822394],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9245136,"threshold_uncertainty_score":0.9999592,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2805592007","doi":"10.1016/s1470-2045(18)30351-6","title":"Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial","year":2018,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":2536,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Merck","keywords":"Medicine; Pembrolizumab; Sorafenib; Internal medicine; Clinical endpoint; Hepatocellular carcinoma; Adverse effect; Response Evaluation Criteria in Solid Tumors; Population; Oncology; Discontinuation; Clinical trial; Phases of clinical research; Surgery; Cancer; Immunotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.07727556601902094,"gpt":0.3280706321942589,"spread":0.2507950661752379,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006522154,0.0004755211,0.001605491,0.0001571592,0.0002100709,0.00005261987,0.0005193806,0.0002228921,0.0001792788],"category_scores_gemma":[0.00006857004,0.0002637832,0.00008132695,0.0005639262,0.0004077969,0.0001785301,0.0001363712,0.0004176062,0.00008097912],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003565189,"about_ca_system_score_gemma":0.0005994593,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003409635,"about_ca_topic_score_gemma":0.0002724214,"domain_scores_codex":[0.9970579,0.0004834506,0.0005541908,0.0006711577,0.0003594835,0.0008737895],"domain_scores_gemma":[0.9980447,0.0002077508,0.0003283086,0.000919019,0.0002603237,0.0002399122],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5517698,0.003345056,0.4360516,0.00003854976,0.0001993847,0.0004277666,0.0006207214,2.838657e-7,0.0001672977,0.00001687184,0.0002803377,0.007082351],"study_design_scores_gemma":[0.9003534,0.06457949,0.02695294,0.000150611,0.0007274512,0.00005724617,0.00005168627,0.00135801,0.001614832,0.00002328879,0.003768486,0.0003625962],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9837359,0.0001898708,0.0000520611,0.0008394131,0.0001212976,0.01018509,0.00002685466,0.00007721362,0.004772302],"genre_scores_gemma":[0.995565,0.0000419341,0.001170686,0.0006509269,0.00051266,0.001356735,0.00024824,0.00008142297,0.0003724127],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4090987,"threshold_uncertainty_score":0.9999815,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4294838953","doi":"10.1016/s0140-6736(22)01200-4","title":"Hepatocellular carcinoma","year":2022,"lang":"en","type":"review","venue":"The Lancet","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":2292,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Hepatocellular carcinoma; Medicine; Sorafenib; Liver transplantation; Percutaneous ethanol injection; Liver function; Viral hepatitis; Alcoholic hepatitis; Carcinoma; Internal medicine; Intensive care medicine; Oncology; Radiofrequency ablation; Transplantation; Alcoholic liver disease; Cirrhosis; Ablation","retraction":null,"screen_n_in":null,"score":{"opus":0.2463423705635389,"gpt":0.3270387073549823,"spread":0.08069633679144336,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004717518,0.0004302222,0.002630448,0.0001088139,0.0002110545,0.00003624479,0.0005026885,0.0001679188,0.003071075],"category_scores_gemma":[0.00004407743,0.0002417688,0.000934105,0.0004083351,0.00006662097,0.00002101614,0.0002063709,0.0008009778,0.0005668225],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000195803,"about_ca_system_score_gemma":0.0003139169,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003028858,"about_ca_topic_score_gemma":5.847198e-7,"domain_scores_codex":[0.9980331,0.0003371113,0.0003992427,0.0003981469,0.000377515,0.000454889],"domain_scores_gemma":[0.9980389,0.000217124,0.0001901268,0.001418335,0.00001655,0.0001189467],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003269282,0.00008905013,0.02708667,0.0118361,0.0005147659,0.001198546,0.00009036696,5.817163e-9,1.471608e-7,0.0002980341,0.02485045,0.9340032],"study_design_scores_gemma":[0.0005178467,0.00013359,0.00005372619,0.00102884,0.003392789,0.0004574875,0.00001004412,0.0000338813,0.000001571862,0.00003311786,0.9941024,0.0002347455],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003553643,0.9853539,0.000001606249,0.0004210607,0.0002549489,0.001610045,0.00009313544,0.0001275299,0.01178235],"genre_scores_gemma":[0.0008847014,0.9927572,0.00005813343,0.0003240353,0.001770375,0.0006984201,0.0007836977,0.0001014494,0.002621958],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9692519,"threshold_uncertainty_score":0.9978402,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2137869551","doi":"10.1016/j.surg.2010.10.001","title":"Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)","year":2011,"lang":"en","type":"article","venue":"Surgery","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":2273,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Grading (engineering); Liver failure; Perioperative; Hepatectomy; Liver function; Complication; Concomitant; Liver function tests; Surgery; Internal medicine; Gastroenterology; Resection","retraction":null,"screen_n_in":null,"score":{"opus":0.2074079014323191,"gpt":0.2293118664463487,"spread":0.02190396501402966,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006112828,0.0001413408,0.0003015762,0.0001697975,0.00006636423,0.00001607538,0.00005446631,0.00005739558,0.0006217858],"category_scores_gemma":[0.00008371932,0.00009804477,0.0001768522,0.0001560287,0.00007234622,0.0001137178,0.00004338754,0.00009833978,0.00004363039],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002738021,"about_ca_system_score_gemma":0.00003372436,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007409739,"about_ca_topic_score_gemma":0.00004937177,"domain_scores_codex":[0.9989804,0.0001136041,0.0002811921,0.0002077721,0.0002490592,0.0001679804],"domain_scores_gemma":[0.9989616,0.0005980049,0.0001178263,0.0001776757,0.00007383743,0.00007102007],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001634122,0.0004983333,0.9846405,0.00003515148,0.0002285207,0.0002071282,0.001234974,1.171645e-9,0.0005937802,0.0000423441,0.006631496,0.00572435],"study_design_scores_gemma":[0.0007193422,0.0002277261,0.9881112,0.000159269,0.0004029594,0.0002012322,0.0008480033,0.0001006285,0.006888587,0.00009646907,0.002003749,0.0002408136],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997207,0.001289397,0.00001692608,0.0001317187,0.0001563897,0.0003413459,0.00001456149,0.0000291964,0.0008134151],"genre_scores_gemma":[0.9991206,0.0003921412,0.00008486801,0.0001104938,0.00005702635,0.00005602577,0.00007294901,0.00001969771,0.00008618154],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006294807,"threshold_uncertainty_score":0.6808118,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2990602950","doi":"10.1200/jco.19.01307","title":"Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1819,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Pembrolizumab; Placebo; Hazard ratio; Internal medicine; Sorafenib; Interim analysis; Adverse effect; Population; Randomized controlled trial; Intention-to-treat analysis; Hepatocellular carcinoma; Subgroup analysis; Surgery; Gastroenterology; Confidence interval; Cancer; Immunotherapy; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.1234301453155467,"gpt":0.4015304858931631,"spread":0.2781003405776164,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004509248,0.0003755119,0.004492629,0.0005286865,0.00002710509,0.0000166743,0.0002370723,0.0006402436,0.00100513],"category_scores_gemma":[0.0006145315,0.0002379902,0.0009813989,0.0004032616,0.0001950951,0.0002532421,0.00004372511,0.001502511,0.00005510644],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002829153,"about_ca_system_score_gemma":0.002032063,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007795037,"about_ca_topic_score_gemma":0.00004930125,"domain_scores_codex":[0.9932193,0.001123513,0.004057764,0.0004475044,0.0006667204,0.0004852366],"domain_scores_gemma":[0.9945769,0.002013534,0.002098855,0.0003826853,0.0004718965,0.0004561065],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5373001,0.006570712,0.4414122,0.00001647788,0.0002393258,0.0009859481,0.0001237513,0.000003561692,0.00001376017,0.00001575986,0.00001703751,0.01330136],"study_design_scores_gemma":[0.8894306,0.07901433,0.02790324,0.0001269848,0.0003068075,0.00006029303,0.00004158542,0.0006670605,0.0002351331,0.00008777357,0.001912446,0.0002137104],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905853,0.0007912428,0.00001246767,0.0008876286,0.000994008,0.005183829,0.000003673034,0.0000111322,0.001530668],"genre_scores_gemma":[0.9974744,0.0003967376,0.0003531143,0.000787123,0.0005123988,0.00009881734,0.00003776605,0.00004747091,0.0002922157],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.413509,"threshold_uncertainty_score":0.9999081,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2234453634","doi":"10.1053/j.gastro.2015.12.041","title":"Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma","year":2016,"lang":"en","type":"review","venue":"Gastroenterology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1771,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Toronto General Hospital; University of Toronto","funders":"Instituto de Salud Carlos III; Albert Einstein Cancer Center","keywords":"Medicine; Hepatocellular carcinoma; Sorafenib; Stage (stratigraphy); Liver transplantation; Liver cancer; Cancer; Internal medicine; Biopsy; Oncology; Radiology; Carcinoma; Transplantation","retraction":null,"screen_n_in":null,"score":{"opus":0.09592117934251783,"gpt":0.2784571507853965,"spread":0.1825359714428787,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009987975,0.0007042968,0.002643716,0.0003807239,0.00004888423,0.00001194317,0.0001196588,0.0002667371,0.0001910025],"category_scores_gemma":[0.00002457085,0.0003956648,0.0005119987,0.0001209998,0.0002689172,0.00006706787,0.00004769752,0.0001219675,0.00002144248],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002715855,"about_ca_system_score_gemma":0.0002448263,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003985232,"about_ca_topic_score_gemma":0.000007054846,"domain_scores_codex":[0.9974542,0.000319672,0.0006709379,0.0007183282,0.0002799029,0.000556976],"domain_scores_gemma":[0.9981753,0.0002548209,0.000503646,0.0006366163,0.0001429148,0.0002867514],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000444789,0.000511397,0.7097592,0.002934714,0.0004597759,0.0001622351,0.00001683815,4.39754e-9,1.647658e-7,0.000001581941,0.00003897358,0.2856703],"study_design_scores_gemma":[0.01389133,0.04434944,0.2107778,0.04282793,0.01338883,0.00009448334,0.000005557675,0.00002325915,0.00004599205,0.000003168259,0.6739827,0.0006095757],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2450128,0.7525515,0.00003216397,0.0001029681,0.00006541002,0.001968207,0.0002298373,0.00002836496,0.000008718793],"genre_scores_gemma":[0.1269603,0.8712342,0.0002733084,0.00005204389,0.00008407734,0.0008745376,0.0003899666,0.00007994501,0.00005158936],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6739437,"threshold_uncertainty_score":0.9998495,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4377011124","doi":"10.1097/hep.0000000000000466","title":"AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","year":2023,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1689,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"National Center for Advancing Translational Sciences; Genentech; National Cancer Institute; Sirtex Medical; Ipsen; Eisai; Exelixis; Gilead Sciences; Boston Scientific Corporation; Cancer Research UK; Incyte; American Association for the Study of Liver Diseases; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Hepatocellular carcinoma; Alice (programming language); Medicine; Philosophy; Art; Art history; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.09575135579406208,"gpt":0.3147161415332554,"spread":0.2189647857391933,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001937866,0.0002483129,0.0005760149,0.0002482364,0.00008410029,0.000008378477,0.00005668283,0.0001757274,0.0001115727],"category_scores_gemma":[0.0001928763,0.0002083187,0.0001699065,0.0003985735,0.0001257465,0.00006807972,0.00003404096,0.00007897329,0.0001897493],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009684257,"about_ca_system_score_gemma":0.0001246149,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002365113,"about_ca_topic_score_gemma":0.00001934996,"domain_scores_codex":[0.9984,0.000197498,0.0003941562,0.0004462874,0.0002123504,0.000349691],"domain_scores_gemma":[0.9986832,0.0004345975,0.0001598354,0.0004294073,0.0001275274,0.000165492],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003281751,0.0007821478,0.9823868,0.00008998736,0.0001982081,0.00128349,0.0003603832,1.416875e-7,0.0003209525,0.001071995,0.001609374,0.01156829],"study_design_scores_gemma":[0.01069884,0.01881056,0.5348192,0.0003043978,0.00200086,0.001088468,0.0004653545,0.01379609,0.1042223,0.0008580607,0.3122174,0.0007184477],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9888895,0.004188061,0.00001393298,0.003753117,0.0001421001,0.0009015941,0.00001823306,0.0001218732,0.00197155],"genre_scores_gemma":[0.9936306,0.003905187,0.0005163343,0.0002415597,0.0000846214,0.0004717424,0.0001132127,0.00003518446,0.001001569],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4475676,"threshold_uncertainty_score":0.8494992,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2153935627","doi":"10.1093/jnci/djn134","title":"Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma","year":2008,"lang":"en","type":"review","venue":"JNCI Journal of the National Cancer Institute","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1664,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"Medicine; Clinical endpoint; Clinical trial; Surrogate endpoint; Clinical study design; Sorafenib; Oncology; Internal medicine; Population; Randomized controlled trial; Hepatocellular carcinoma; Liver function; Intensive care medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.6514346438688952,"gpt":0.4969074105035567,"spread":0.1545272333653385,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006659358,0.0003113324,0.003878054,0.0004511206,0.00005601644,0.00001204363,0.0002758386,0.0003710389,0.0000424235],"category_scores_gemma":[0.003342211,0.0001755201,0.001712486,0.0004238115,0.0002253644,0.0001353942,0.00006548098,0.0008209622,0.000002694308],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003903559,"about_ca_system_score_gemma":0.00515126,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000417576,"about_ca_topic_score_gemma":0.000005283846,"domain_scores_codex":[0.993164,0.001753205,0.003694169,0.0002291456,0.0009902446,0.0001692487],"domain_scores_gemma":[0.9943908,0.001460396,0.003268185,0.0001624518,0.0005577778,0.0001603305],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008170395,0.0005750931,0.1855176,0.006073536,0.002310504,0.0008846368,0.000162259,0.00001977374,0.00001198952,0.0001315509,0.005209512,0.7982865],"study_design_scores_gemma":[0.004095663,0.0003570002,0.003000437,0.0152272,0.003080344,0.002253441,0.000003393103,0.0003457099,0.000148034,0.0001409435,0.9710969,0.000250905],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.008836294,0.9879879,0.00006984267,0.0002063885,0.00141818,0.00127583,0.00005042431,0.000002958765,0.0001521726],"genre_scores_gemma":[0.02277515,0.9745989,0.001096913,0.00009370255,0.00123435,0.00004400067,0.00001147266,0.00002614702,0.0001193863],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9658874,"threshold_uncertainty_score":0.9138114,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2017019986","doi":"10.1097/sla.0b013e3181b3b2d8","title":"The International Position on Laparoscopic Liver Surgery","year":2009,"lang":"en","type":"article","venue":"Annals of Surgery","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1517,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Laparoscopy; Laparoscopic surgery; General surgery; Presentation (obstetrics); Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.4479584205930773,"gpt":0.3243690662106516,"spread":0.1235893543824257,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004045313,0.00008904862,0.0002204022,0.0001225933,0.00006329324,0.00001847485,0.00004568322,0.00004866455,0.0001726726],"category_scores_gemma":[0.0001289361,0.00006039482,0.0002703612,0.0001069792,0.00003370063,0.00006289536,0.000007240949,0.00006395335,0.0001435805],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001183674,"about_ca_system_score_gemma":0.00006102633,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000146135,"about_ca_topic_score_gemma":6.456765e-7,"domain_scores_codex":[0.9991822,0.00003739955,0.0002376769,0.0001194737,0.0002600471,0.0001631795],"domain_scores_gemma":[0.9988375,0.0007155509,0.00008996675,0.0001700885,0.0001237553,0.00006318408],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005376228,0.0004116867,0.6803156,0.00002174651,0.000161355,0.0001817947,0.00004570592,2.981955e-7,0.001336842,0.0004381159,0.2163411,0.1002081],"study_design_scores_gemma":[0.0002345423,0.0002155708,0.792207,0.0003599905,0.00005079922,0.00003149733,0.00001836456,0.0001154473,0.1708046,0.0003089116,0.03550874,0.0001445592],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9746214,0.001167508,0.000002417935,0.0184541,0.0002975901,0.00009660189,0.000006148822,0.00002026551,0.005333928],"genre_scores_gemma":[0.993807,0.002233091,0.000009286574,0.002825564,0.0001674972,0.000007007512,0.0000640266,0.000006625513,0.0008799349],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1808324,"threshold_uncertainty_score":0.2462829,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4281645619","doi":"10.1056/evidoa2100070","title":"Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma","year":2022,"lang":"en","type":"article","venue":"NEJM Evidence","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1432,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"AstraZeneca","keywords":"Durvalumab; Tremelimumab; Medicine; Hazard ratio; Sorafenib; Hepatocellular carcinoma; Internal medicine; Confidence interval; Oncology; Regimen; Urology; Surgery; Cancer; Immunotherapy; Nivolumab; Ipilimumab","retraction":null,"screen_n_in":null,"score":{"opus":0.1253603055975009,"gpt":0.2842659688337804,"spread":0.1589056632362795,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007198726,0.0002683561,0.000499189,0.0003215134,0.0002659784,0.00003419317,0.0002823809,0.00007795273,0.002282412],"category_scores_gemma":[0.0001824327,0.0002684049,0.000208289,0.0009559687,0.00006036224,0.0002275496,0.0002645243,0.000507633,0.0001584343],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009774878,"about_ca_system_score_gemma":0.0005847681,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002187779,"about_ca_topic_score_gemma":0.00007052842,"domain_scores_codex":[0.9972417,0.0003038702,0.0004377116,0.0006134406,0.0008140996,0.0005891703],"domain_scores_gemma":[0.9987537,0.0002121113,0.00009511099,0.0006535787,0.00007305883,0.0002124033],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006579185,0.0002068017,0.9872373,0.0001119204,0.00002881507,0.002862541,0.0007680964,0.0000274319,0.004143002,0.0001041329,0.001074583,0.002777499],"study_design_scores_gemma":[0.02297381,0.00727564,0.6174759,0.00116545,0.000910465,0.0020261,0.002824775,0.2287391,0.04237446,0.0006541302,0.07147742,0.002102773],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9828695,0.01122475,0.00002832195,0.001620234,0.0002143262,0.001074245,0.000009937993,0.00010374,0.002854961],"genre_scores_gemma":[0.9947544,0.000167658,0.0002442984,0.0004459109,0.0001092019,0.0005522307,0.0000422847,0.00004846392,0.003635514],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3697614,"threshold_uncertainty_score":0.9999768,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1840728003","doi":"10.1097/sla.0000000000001184","title":"Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka.","year":2015,"lang":"en","type":"article","venue":"PubMed","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1336,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; University of Toronto","funders":"","keywords":"Consensus conference; Resection; General surgery; Medicine; Medical physics; Surgery; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.2492952483004384,"gpt":0.3022885340844609,"spread":0.05299328578402249,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003888459,0.00008264552,0.0001446517,0.00005168395,0.00004041231,0.00003523307,0.0000725307,0.00005930998,0.0002447647],"category_scores_gemma":[0.0003948818,0.00006159471,0.00005213741,0.00009457959,0.00003844402,0.00004573726,0.00002801951,0.0001077745,0.00001270572],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000122611,"about_ca_system_score_gemma":0.0001084159,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003849025,"about_ca_topic_score_gemma":0.001365685,"domain_scores_codex":[0.9992152,0.00004797494,0.0002304245,0.0002019243,0.0001394107,0.0001650836],"domain_scores_gemma":[0.9992322,0.0002142579,0.00007431149,0.0002002535,0.000170252,0.0001087655],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003743907,0.0001407619,0.8818675,0.00001194942,0.0001493245,0.0002380744,0.0006488736,1.554547e-7,0.00001696804,0.000168187,0.09961858,0.01676522],"study_design_scores_gemma":[0.005275877,0.00009800737,0.414109,0.00004219474,0.0001078045,0.000172194,0.000517771,0.0009387056,0.002926873,0.00123534,0.5744308,0.0001454285],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9512546,0.0003793155,0.0000692614,0.03565541,0.0009967495,0.001692704,0.0001133699,0.00003513831,0.009803455],"genre_scores_gemma":[0.9869862,0.00001732322,0.0006719433,0.0004640043,0.0003153811,0.002468582,0.0003496024,0.000009274533,0.008717705],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4748122,"threshold_uncertainty_score":0.2680002,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2096759906","doi":"10.1148/radiol.14132958","title":"Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria—A 10-Year Update","year":2014,"lang":"en","type":"article","venue":"Radiology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1334,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Terminology; Cryoablation; Medical physics; Standardization; Ablative case; Modalities; Radiofrequency ablation; Common Terminology Criteria for Adverse Events; Ablation; Radiology; Computer science; Radiation therapy","retraction":null,"screen_n_in":null,"score":{"opus":0.06538052800806674,"gpt":0.3097841839487658,"spread":0.244403655940699,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004935384,0.00009641571,0.0004224889,0.0000907049,0.00004024993,0.000005908747,0.00002830943,0.00008298983,0.000415872],"category_scores_gemma":[0.0006581371,0.0000819339,0.00005150435,0.00006826413,0.0001230938,0.00004496383,0.00002292724,0.00005461732,0.00001414308],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002131421,"about_ca_system_score_gemma":0.00003834425,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009063047,"about_ca_topic_score_gemma":9.689102e-7,"domain_scores_codex":[0.9988746,0.0001285279,0.0005661069,0.0002118584,0.00006410182,0.0001548101],"domain_scores_gemma":[0.9991469,0.00006093768,0.0004182382,0.0001959736,0.000119813,0.00005813798],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001693029,0.00003356831,0.9479448,0.000130321,0.00008173377,0.0001405072,0.0001370756,6.64665e-7,0.0431324,0.0008939407,0.002887668,0.004448039],"study_design_scores_gemma":[0.01019602,0.003781336,0.735462,0.0001919447,0.001020965,0.008744174,0.0001425227,0.02600236,0.126697,0.00321537,0.08388284,0.0006634985],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912457,0.0001981386,0.004036975,0.0007655318,0.0000909666,0.0002032915,0.000006112475,0.00003845587,0.003414777],"genre_scores_gemma":[0.9899039,0.00003209596,0.009512507,0.0001413217,0.0001394182,0.00001132877,0.0001042646,0.00001268353,0.0001424837],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2124828,"threshold_uncertainty_score":0.4553507,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2028319026","doi":"10.1111/liv.12818","title":"Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study","year":2015,"lang":"en","type":"article","venue":"Liver International","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1256,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Bristol-Myers Squibb","keywords":"Medicine; Hepatocellular carcinoma; Percutaneous ethanol injection; China; Liver cancer; Cohort; Internal medicine; Demography; Radiofrequency ablation; Geography; Ablation","retraction":null,"screen_n_in":null,"score":{"opus":0.09976613369820149,"gpt":0.2844668581424876,"spread":0.1847007244442861,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002070819,0.0002103552,0.0002569376,0.000100532,0.00004337708,0.00004306269,0.0003823009,0.00005318735,0.0001582196],"category_scores_gemma":[0.00006557879,0.0001568485,0.0001620939,0.0001679605,0.00002298887,0.00007558202,0.0002808746,0.00008198471,0.0001944923],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002428796,"about_ca_system_score_gemma":0.00004321176,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002990637,"about_ca_topic_score_gemma":0.00009336738,"domain_scores_codex":[0.9981617,0.00008638709,0.0003254865,0.0003727908,0.0008329753,0.0002207043],"domain_scores_gemma":[0.9989235,0.0001114236,0.00009541964,0.0004081768,0.000229005,0.0002324801],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00004313848,0.0009137505,0.9905798,0.00001316137,0.000655111,0.0007832178,0.001656851,0.000003463296,0.000005567279,0.0004870562,0.002386501,0.002472397],"study_design_scores_gemma":[0.001982216,0.0004935645,0.9840559,0.00004217888,0.0004556424,0.00001434608,0.001018907,0.0009944349,0.0007815464,0.0001624797,0.009941399,0.00005738331],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906438,0.0003827842,0.0005149329,0.0004302505,0.0004972181,0.001214495,0.0002880004,0.00003862047,0.005989898],"genre_scores_gemma":[0.9972671,0.00002745456,0.0004776085,0.0003784762,0.0002923067,0.0003085229,0.0001864277,0.00001933015,0.00104281],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007554898,"threshold_uncertainty_score":0.6396098,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3032651552","doi":"10.1200/jco.20.00818","title":"Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1242,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Surrey Place Centre; Nova Scotia Cancer Centre; Health Sciences Centre; McGill University Health Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Positive Living North; London Health Sciences Centre","funders":"","keywords":"Medicine; SABR volatility model; Randomized controlled trial; Clinical endpoint; Radiation therapy; Radiosurgery; Prostate cancer; Internal medicine; Ablative case; Oncology; Quality of life (healthcare); Surgery; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.3547905206584541,"gpt":0.4845785244643184,"spread":0.1297880038058644,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001805095,0.0001965834,0.003316318,0.00007015007,0.00006929724,0.00000540656,0.0001942263,0.0001611185,0.0000740027],"category_scores_gemma":[0.003292993,0.00008369399,0.002076422,0.0002106065,0.0005261935,0.0000524398,0.00002425256,0.0002842062,6.027362e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002040154,"about_ca_system_score_gemma":0.001407807,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004549724,"about_ca_topic_score_gemma":0.00001304094,"domain_scores_codex":[0.9947397,0.001477212,0.003087616,0.0001786519,0.0003383915,0.0001784752],"domain_scores_gemma":[0.9755659,0.01965893,0.003808167,0.0002484622,0.000509685,0.0002089026],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9237702,0.003580077,0.00571015,0.00005044684,0.00844685,0.00008634174,0.002193057,0.000009949778,0.00022395,0.00001332522,0.0003797353,0.05553589],"study_design_scores_gemma":[0.8721866,0.111239,0.002654957,0.0000772653,0.005387204,0.00003502244,0.0001372981,0.001303155,0.001118427,0.00003467924,0.005762626,0.00006373445],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9737605,0.003812852,0.0004261052,0.01740051,0.0008861148,0.003562263,0.00006369584,0.000003558082,0.00008437788],"genre_scores_gemma":[0.9933854,0.003294953,0.001298754,0.0009944745,0.0008413334,0.00006036021,0.000006829835,0.00001702515,0.0001009207],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1076589,"threshold_uncertainty_score":0.3942258,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3090413519","doi":"10.1001/jamaoncol.2020.4564","title":"Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1212,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Tolerability; Internal medicine; Sorafenib; Hepatocellular carcinoma; Adverse effect; Randomized controlled trial; Surgery; Gastroenterology; Oncology; Cancer; Immunotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.023995485520902,"gpt":0.2317533058969982,"spread":0.2077578203760962,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001102628,0.0003067554,0.0009543969,0.0001275571,0.00004889431,0.000009243133,0.00009365212,0.0002230116,0.00005568265],"category_scores_gemma":[0.00006113968,0.0002221654,0.000063466,0.0004487536,0.0001864194,0.0001154158,0.00005623144,0.0002813768,0.000008907393],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002892873,"about_ca_system_score_gemma":0.0003720966,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001446771,"about_ca_topic_score_gemma":0.00005004143,"domain_scores_codex":[0.998207,0.0001603407,0.0004523515,0.0005227741,0.0002614518,0.0003960505],"domain_scores_gemma":[0.99891,0.0001331689,0.0002087807,0.0002770147,0.0001723989,0.0002986274],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03483114,0.0006886204,0.9416983,0.0001980822,0.0001562057,0.0006551055,0.001329719,0.000006015737,0.0002675622,0.00001865006,0.00004138757,0.02010917],"study_design_scores_gemma":[0.09243507,0.02387923,0.8758689,0.0001929431,0.0004697821,0.00003343372,0.0001559943,0.001917701,0.002480461,0.000002343946,0.002288205,0.0002759427],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947886,0.0006169438,0.00002658973,0.001066659,0.00001525949,0.002404269,0.0000178839,0.00005506717,0.001008653],"genre_scores_gemma":[0.9980942,0.00006523076,0.001118808,0.0003095015,0.00003762009,0.00008594119,0.0001848283,0.00004931338,0.00005454699],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06582944,"threshold_uncertainty_score":0.905964,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2136415416","doi":"10.1158/0008-5472.can-09-1089","title":"Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma","year":2009,"lang":"en","type":"article","venue":"Cancer Research","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1206,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; RIKEN; Howard Hughes Medical Institute","keywords":"Wnt signaling pathway; Hepatocellular carcinoma; Transcriptome; Cancer research; Biology; Gene; Cancer; Computational biology; Liver cancer; Gene expression; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.138991460749862,"gpt":0.4005337659510201,"spread":0.2615423052011581,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007797436,0.0002542013,0.0008984603,0.001000783,0.0001606798,0.00003355741,0.0002636164,0.0001627294,0.0005238872],"category_scores_gemma":[0.00004556787,0.0002049096,0.0005472847,0.002616816,0.0002599992,0.00008632356,0.00003071577,0.0005239905,0.00001388235],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002999329,"about_ca_system_score_gemma":0.0002254748,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00135252,"about_ca_topic_score_gemma":0.00008301808,"domain_scores_codex":[0.997053,0.0004302085,0.0004773992,0.0004922749,0.0009587789,0.0005883881],"domain_scores_gemma":[0.9981915,0.00009339073,0.00008774165,0.0006539158,0.0006645239,0.0003089496],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001356212,0.0002087927,0.5469722,0.00007185372,0.0005001502,0.0003280271,0.0006018191,6.015784e-7,0.4494442,0.0006680542,0.0003157301,0.0007530277],"study_design_scores_gemma":[0.001417132,0.001940152,0.2013602,0.0001813723,0.0014258,0.000006728011,0.0003943032,0.0005027771,0.7910655,0.001035413,0.0004417125,0.0002289444],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886835,0.005784167,0.00008713109,0.001237722,0.00002874691,0.0009238482,0.00004129378,0.0000403656,0.003173264],"genre_scores_gemma":[0.9980592,0.0002138106,0.0001081252,0.0001138253,0.00007843209,0.0001435171,0.0001438408,0.00002767552,0.001111552],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.345612,"threshold_uncertainty_score":0.835597,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3035408975","doi":"10.1038/s41392-020-0187-x","title":"The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects","year":2020,"lang":"en","type":"review","venue":"Signal Transduction and Targeted Therapy","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1132,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Sorafenib; Hepatocellular carcinoma; Resistance (ecology); Medicine; Oncology; Bioinformatics; Internal medicine; Cancer research; Computational biology; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.05311660016790334,"gpt":0.2674391736520976,"spread":0.2143225734841942,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004019548,0.0004861525,0.001438981,0.0001731324,0.0001492085,0.00003574887,0.0001113726,0.0003189012,0.0002017276],"category_scores_gemma":[0.00001006298,0.0003014674,0.000407952,0.0004836381,0.0004060756,0.00003571783,0.00001218003,0.0004901107,0.000003268657],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005104807,"about_ca_system_score_gemma":0.0002035778,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001208475,"about_ca_topic_score_gemma":0.000006079937,"domain_scores_codex":[0.9977271,0.0004676162,0.000636398,0.0005438469,0.0003098916,0.000315177],"domain_scores_gemma":[0.9990881,0.0002424416,0.0001763716,0.0002544208,0.0000596366,0.0001790383],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001131135,0.0002758131,0.001406289,0.004965956,0.001032131,0.0002999823,0.0009018878,2.141599e-8,0.0008500286,0.09141394,0.00001029939,0.8977125],"study_design_scores_gemma":[0.008284951,0.002678805,0.0005172527,0.005433303,0.003787639,0.0003450739,0.000431391,0.000500362,0.01338042,0.07384063,0.8893759,0.001424256],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003159391,0.9937254,0.0002792071,0.00076883,0.00009018378,0.001699863,0.00002879729,0.00003821407,0.0002100668],"genre_scores_gemma":[0.3958434,0.6037465,0.0001171821,0.00003964747,0.0000546272,0.0000950509,0.00003142935,0.00004373865,0.00002836546],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8962883,"threshold_uncertainty_score":0.9999437,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2893608205","doi":"10.1148/radiol.2018181494","title":"Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients","year":2018,"lang":"en","type":"review","venue":"Radiology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1115,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Context (archaeology); Radiology; Lexicon; Medical physics; Magnetic resonance imaging; Artificial intelligence; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.09218366801745587,"gpt":0.3000141684306824,"spread":0.2078305004132265,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001501944,0.0005564821,0.002852474,0.0005113964,0.0001212668,0.00001333406,0.0003460834,0.0003244108,0.00003410316],"category_scores_gemma":[0.0004876673,0.0004560587,0.0003202985,0.0002781224,0.000241204,0.0001246645,0.0007540457,0.0004157347,0.00005937544],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005864507,"about_ca_system_score_gemma":0.0002268142,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007228001,"about_ca_topic_score_gemma":0.000009853078,"domain_scores_codex":[0.9952582,0.000634973,0.002101637,0.001213884,0.0002511198,0.0005401819],"domain_scores_gemma":[0.9952551,0.0002326067,0.002739026,0.001468651,0.0001181659,0.0001864625],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004119782,0.00005867232,0.8802188,0.01290284,0.000151714,0.001642176,0.00009137287,1.130358e-8,0.00000144345,0.000002836592,0.0008925532,0.1039964],"study_design_scores_gemma":[0.006993935,0.0007772211,0.09391318,0.0519021,0.01445015,0.009768662,0.0001928029,0.04561207,0.00004433905,0.000006375094,0.7745274,0.001811746],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2147651,0.7832603,0.00001169723,0.000008950748,0.0003204891,0.001213399,0.0001726842,0.0000388019,0.000208618],"genre_scores_gemma":[0.3588158,0.6386197,0.0002046286,0.000009534884,0.0001952088,0.000034641,0.002017716,0.0000683771,0.00003443417],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7863056,"threshold_uncertainty_score":0.9997891,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2011890969","doi":"10.1097/01.sla.0000160703.75808.7d","title":"Effect of Surgical Margin Status on Survival and Site of Recurrence After Hepatic Resection for Colorectal Metastases","year":2005,"lang":"en","type":"article","venue":"Annals of Surgery","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1098,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Medicine; Carcinoembryonic antigen; Resection margin; Surgical margin; Demographics; Overall survival; Gastroenterology; Surgery; Internal medicine; Resection; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.1751139616042645,"gpt":0.3411871441439286,"spread":0.1660731825396641,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001143923,0.0001301663,0.0006309111,0.000194488,0.00001625444,0.000003180263,0.00001595289,0.00006303668,0.00005524531],"category_scores_gemma":[0.000277475,0.0000990866,0.0002671259,0.0001592075,0.00009109548,0.00006331437,0.00001367421,0.0000555742,0.000001789011],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008560353,"about_ca_system_score_gemma":0.00004314405,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007151479,"about_ca_topic_score_gemma":0.00001799056,"domain_scores_codex":[0.9988117,0.0002203508,0.0003660935,0.0001699934,0.0002262322,0.0002055874],"domain_scores_gemma":[0.996847,0.002633527,0.0001562971,0.0001235534,0.0001466889,0.00009296324],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0148305,0.0002587342,0.951194,0.0008889999,0.0001479182,0.00003020611,0.00006532733,5.788438e-7,0.001108086,0.00001104687,0.0004719025,0.03099263],"study_design_scores_gemma":[0.001649431,0.006178699,0.2136522,0.0006457365,0.000308708,0.00001337929,0.00001396769,0.0003306364,0.7747507,0.00001268936,0.00230089,0.0001429621],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962183,0.002721724,0.000002848508,0.0002286461,0.00006807839,0.0004404705,0.0002066634,0.000007785509,0.0001054776],"genre_scores_gemma":[0.9983413,0.001335902,0.00005921485,0.00001208067,0.00005405827,0.00006312529,0.00009578025,0.0000118846,0.00002667563],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7736426,"threshold_uncertainty_score":0.4040634,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2161689638","doi":"10.1016/s1470-2045(11)70175-9","title":"Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report","year":2011,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1028,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Hepatocellular carcinoma; Liver transplantation; Transplantation; Consensus conference; Listing (finance); Donation; Family medicine; Internal medicine; Political science; Law","retraction":null,"screen_n_in":null,"score":{"opus":0.3238269917420179,"gpt":0.3579941574896356,"spread":0.03416716574761769,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005455621,0.000114208,0.0002894036,0.00005038437,0.0001185525,0.000009899211,0.0001351713,0.0001079975,0.0002426555],"category_scores_gemma":[0.00006060768,0.00008404804,0.0001037779,0.00004336895,0.00008508317,0.00005253317,0.00001061874,0.00009154808,0.00001043165],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007649895,"about_ca_system_score_gemma":0.0001735966,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001428544,"about_ca_topic_score_gemma":0.00008122963,"domain_scores_codex":[0.9991122,0.00009164185,0.0002679465,0.0002355781,0.00007522889,0.0002173324],"domain_scores_gemma":[0.9990556,0.0002175436,0.0001361125,0.0002704435,0.0002474639,0.00007285395],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006885692,0.00100538,0.9117855,0.0002928759,0.0004841633,0.001857377,0.009229869,2.693343e-7,0.002652665,0.02642221,0.01226849,0.0271155],"study_design_scores_gemma":[0.02456467,0.007811646,0.1775196,0.000100961,0.002993569,0.007750353,0.001314498,0.05331543,0.03644729,0.008928683,0.6785483,0.0007049508],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.963594,0.000086031,0.01034032,0.01400519,0.0006029145,0.001916698,0.0002259014,0.00007598497,0.009152965],"genre_scores_gemma":[0.9668106,0.0001637412,0.02955289,0.0006041966,0.0004481109,0.0006464468,0.001228759,0.00001727841,0.0005279888],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7342659,"threshold_uncertainty_score":0.342738,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2138378598","doi":"10.1016/j.ultrasmedbio.2012.09.002","title":"Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver – Update 2012","year":2012,"lang":"en","type":"article","venue":"Ultrasound in Medicine & Biology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":968,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Toshiba Medical Systems; Lantheus Medical Imaging; GE Healthcare; Bracco Group; Philips Medical Systems","keywords":"Contrast-enhanced ultrasound; Medicine; Ultrasound; Medical physics; Contrast (vision); Diagnostic ultrasound; Ultrasound imaging; Radiology; Ultrasonography; Computer science","retraction":null,"screen_n_in":null,"score":{"opus":0.1863006539347128,"gpt":0.4227213473154021,"spread":0.2364206933806893,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004375912,0.0002594292,0.0006437416,0.000162829,0.00009593361,0.00001228793,0.0001456942,0.0002524867,0.0003328541],"category_scores_gemma":[0.01125711,0.0001581435,0.00009305468,0.000272917,0.00038901,0.0002482768,0.00002117833,0.00045305,0.00002979508],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004959187,"about_ca_system_score_gemma":0.00006708877,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002491522,"about_ca_topic_score_gemma":0.0002149071,"domain_scores_codex":[0.99727,0.0006402035,0.001012735,0.0003789125,0.0001376124,0.0005605326],"domain_scores_gemma":[0.9881626,0.01089849,0.0002254436,0.0003288402,0.0002092326,0.0001753938],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004898163,0.0008648456,0.8865678,0.00005375214,0.000161848,0.00001423143,0.00215761,5.717558e-8,0.004222687,0.003335552,0.02585845,0.07627331],"study_design_scores_gemma":[0.006784727,0.001608502,0.1343166,0.0001758655,0.0005681717,0.0005061644,0.002477126,0.00003574794,0.0002945194,0.0006505807,0.8523243,0.0002577038],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8726519,0.03340139,0.004088381,0.07732278,0.001511154,0.003364927,0.00008573759,0.00006350328,0.007510266],"genre_scores_gemma":[0.9594735,0.01820541,0.009299304,0.0106377,0.001356612,0.0002454945,0.000649889,0.00002279861,0.0001093016],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8264658,"threshold_uncertainty_score":0.9970715,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2106285087","doi":"10.1016/s0016-5085(03)00689-9","title":"Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma","year":2003,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":907,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; University of Toronto; Toronto General Hospital; Sunnybrook Health Science Centre","funders":"Cancer Research Society","keywords":"Glypican 3; Hepatocellular carcinoma; HCCS; Cirrhosis; Medicine; Immunohistochemistry; Internal medicine; Alpha-fetoprotein; Pathology; Differential diagnosis; Gastroenterology; Hepatitis; Tumor marker; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.03896985502854543,"gpt":0.2353357537616456,"spread":0.1963658987331002,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001604913,0.000215562,0.0003923373,0.00008898364,0.00006524525,0.000009477269,0.00005239538,0.0001384427,0.0001273588],"category_scores_gemma":[0.00006231241,0.0001944854,0.0001563325,0.00005112646,0.0001257945,0.00003216874,0.00002938723,0.0001293687,0.000009117608],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000681038,"about_ca_system_score_gemma":0.00004136862,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001163554,"about_ca_topic_score_gemma":0.000007557943,"domain_scores_codex":[0.9986959,0.00004778209,0.0002458412,0.0004073223,0.000100432,0.0005026858],"domain_scores_gemma":[0.9993411,0.0000452796,0.0000572079,0.0002494984,0.00006336285,0.0002435064],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008837296,0.0001914162,0.9750298,0.00006537764,0.00009489831,0.00006219666,0.00004954353,2.514755e-8,0.02256341,0.0002832868,0.0005700299,0.0002063396],"study_design_scores_gemma":[0.01751912,0.004668621,0.9134327,0.00004053661,0.0007845407,0.002481239,0.00007940977,0.003168324,0.01512008,0.0002487587,0.04214763,0.000309046],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942727,0.0003727014,0.002822675,0.001226441,0.0001175625,0.0007615071,0.00003301231,0.00004141411,0.0003519764],"genre_scores_gemma":[0.9892916,0.000009406351,0.008929539,0.0009781972,0.00006819922,0.0002032402,0.00005605239,0.00003384429,0.0004299062],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06159705,"threshold_uncertainty_score":0.7930885,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2133685049","doi":"10.1200/jco.2012.44.1659","title":"Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":834,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Hepatocellular carcinoma; Oncology; Radiation therapy; Internal medicine; Radiology","retraction":null,"screen_n_in":null,"score":{"opus":0.2590101692519884,"gpt":0.4646096921430163,"spread":0.2055995228910279,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005055843,0.0002002084,0.003018637,0.0001624211,0.00005636759,0.00001177467,0.0001185392,0.0003891603,0.0004298179],"category_scores_gemma":[0.003155052,0.0001352358,0.001067717,0.00009074989,0.0002100802,0.0001821804,0.00003167348,0.0003979293,0.000002812158],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009051935,"about_ca_system_score_gemma":0.001088693,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002731579,"about_ca_topic_score_gemma":0.000001664621,"domain_scores_codex":[0.9946674,0.0007583927,0.00381078,0.0002231189,0.0002799143,0.0002604509],"domain_scores_gemma":[0.9925717,0.003254972,0.002815032,0.0002048368,0.0006831239,0.0004703153],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.01807198,0.004722318,0.5901496,0.0001778835,0.001997405,0.0005382804,0.0002185908,4.671035e-7,0.03800079,0.00009416041,0.001836309,0.3441921],"study_design_scores_gemma":[0.2997878,0.3484052,0.1002674,0.0005318482,0.007864609,0.00179638,0.0002895015,0.01962433,0.03833568,0.001723715,0.180679,0.0006945568],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9885845,0.003821761,0.001603707,0.003630745,0.0006992682,0.001509306,0.00001366872,0.000007405438,0.0001297003],"genre_scores_gemma":[0.9861757,0.0009982394,0.01096375,0.000619468,0.0009585477,0.00004065116,0.00001053414,0.00002783444,0.0002052859],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4898823,"threshold_uncertainty_score":0.5514756,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2058887247","doi":"10.1016/j.jhep.2012.06.014","title":"Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial","year":2012,"lang":"en","type":"article","venue":"Journal of Hepatology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":821,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Instituto de Salud Carlos III; Bayer HealthCare; Onyx Pharmaceuticals; National Institutes of Health; Ministerio de Ciencia e Innovación; European Commission","keywords":"Sorafenib; Medicine; Internal medicine; Hepatocellular carcinoma; Placebo; Hazard ratio; Adverse effect; Subgroup analysis; Oncology; Randomized controlled trial; Gastroenterology; Surgery; Confidence interval; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.03640248984324077,"gpt":0.2820490078989289,"spread":0.2456465180556881,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004369233,0.0001965236,0.001257028,0.0004195239,0.00002452094,0.000002372353,0.0000809565,0.0001349666,0.00005265925],"category_scores_gemma":[0.0001187833,0.0001375958,0.000177974,0.0002800148,0.0001564024,0.0001588644,0.00002830942,0.000213023,6.969676e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006211932,"about_ca_system_score_gemma":0.0001790983,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004903078,"about_ca_topic_score_gemma":0.000006259637,"domain_scores_codex":[0.9979971,0.0001769433,0.001071274,0.0001393561,0.0003147294,0.0003005977],"domain_scores_gemma":[0.9982831,0.0001864674,0.0008472735,0.0001962184,0.0002811926,0.0002057267],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1498627,0.003012417,0.8428681,0.00008193484,0.0002792419,0.00009468601,0.0003920785,4.192117e-7,0.0009060024,0.00002152403,0.00001201771,0.002468923],"study_design_scores_gemma":[0.4892155,0.01503225,0.4733277,0.0001872121,0.001539202,0.0001927388,0.0001124539,0.0002320679,0.01971402,0.0000141992,0.0002302066,0.0002024106],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959813,0.002970531,0.00004887709,0.00009085792,0.0001219352,0.0007098538,0.000007905443,0.00000360109,0.00006514734],"genre_scores_gemma":[0.998957,0.00009657603,0.0008130567,0.00002052378,0.00006361047,0.000006114768,0.00001683107,0.00001896368,0.00000734235],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3695403,"threshold_uncertainty_score":0.5610992,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2996066981","doi":"10.1136/gutjnl-2019-318934","title":"Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial","year":2019,"lang":"en","type":"article","venue":"Gut","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":723,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pancreas Centre (Canada)","funders":"Bayer Yakuhin","keywords":"Sorafenib; Medicine; Hepatocellular carcinoma; Internal medicine; Clinical endpoint; Gastroenterology; Adverse effect; Response Evaluation Criteria in Solid Tumors; Progression-free survival; Oncology; Randomized controlled trial; Clinical trial; Overall survival; Phases of clinical research","retraction":null,"screen_n_in":null,"score":{"opus":0.01871837646052252,"gpt":0.2217589412652851,"spread":0.2030405648047626,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002534465,0.0003935375,0.001212417,0.0001783078,0.000052018,0.00002984293,0.0001081893,0.0001926501,0.0001893354],"category_scores_gemma":[0.00005222673,0.0002909586,0.0001832251,0.0003359488,0.00009388485,0.0001917256,0.00001726015,0.0002445651,0.00004741419],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002824954,"about_ca_system_score_gemma":0.0004242749,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003693898,"about_ca_topic_score_gemma":0.00005478907,"domain_scores_codex":[0.9975169,0.0001776413,0.0006366317,0.0005337395,0.0007245548,0.0004105183],"domain_scores_gemma":[0.9986432,0.0001182262,0.0003477993,0.0004487252,0.0002691881,0.0001728782],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5417256,0.001294856,0.4545598,0.00008576478,0.0001709734,0.00004412698,0.001641578,0.000007688124,0.0003553306,0.000006320224,0.000007851797,0.0001001244],"study_design_scores_gemma":[0.9289415,0.008506479,0.04953874,0.0001292039,0.0007554614,0.00000517999,0.0002947251,0.002049278,0.009375988,0.000006718822,0.00007745915,0.0003192176],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9833059,0.00005758183,0.00006526379,0.00008419535,0.0003379843,0.0154449,0.0000287189,0.00004344638,0.0006319604],"genre_scores_gemma":[0.9983442,0.000005057713,0.0004585682,0.00002278335,0.0002164446,0.0002940057,0.0003812668,0.00006038966,0.0002172327],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.405021,"threshold_uncertainty_score":0.9999543,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1570173114","doi":"10.1097/01.rvi.0000233785.75257.9a","title":"Radioembolization with 90Yttrium Microspheres: A State-of-the-Art Brachytherapy Treatment for Primary and Secondary Liver Malignancies","year":2006,"lang":"en","type":"review","venue":"Journal of Vascular and Interventional Radiology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":678,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Nordion (Canada)","funders":"","keywords":"Subspecialty; Medicine; Microsphere; Interventional radiology; Brachytherapy; Selective internal radiation therapy; Medical physics; Radiology; Internal medicine; Radiation therapy; Pathology; Hepatocellular carcinoma","retraction":null,"screen_n_in":null,"score":{"opus":0.04355254666261291,"gpt":0.2825063538859681,"spread":0.2389538072233552,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002888997,0.0002798065,0.001564321,0.0001439044,0.00005876464,0.00001659219,0.00007006484,0.0001545445,0.00003722684],"category_scores_gemma":[0.00001574813,0.0001506315,0.001391726,0.00008827348,0.0001736439,0.0000701313,0.0000183383,0.0001559912,4.997416e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000139364,"about_ca_system_score_gemma":0.0003802174,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001072357,"about_ca_topic_score_gemma":0.00001093797,"domain_scores_codex":[0.9985401,0.0002031684,0.0007572052,0.0001967128,0.0001501414,0.0001526598],"domain_scores_gemma":[0.9987438,0.0001413967,0.0007281044,0.0001336744,0.0001816833,0.00007137073],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005789149,0.0007258736,0.01131323,0.01702194,0.007553214,0.0001334266,0.0001022826,0.000001359199,0.00003731531,0.0001397975,0.002272666,0.96012],"study_design_scores_gemma":[0.004617741,0.00628454,0.005635965,0.007247748,0.005229475,0.006573466,0.000006296496,0.00001619097,0.00005735713,0.00008660155,0.9640594,0.0001852063],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01285025,0.9843559,0.001600574,0.00004301879,0.000108747,0.0009169598,0.00008494446,0.000003195627,0.00003642699],"genre_scores_gemma":[0.001048912,0.9963704,0.001429748,0.00003527149,0.0001619004,0.00005284627,0.0002072519,0.00003314156,0.0006605414],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9617867,"threshold_uncertainty_score":0.6142575,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2147188187","doi":"10.1016/j.ijrobp.2006.11.060","title":"Recommendations for Radioembolization of Hepatic Malignancies Using Yttrium-90 Microsphere Brachytherapy: A Consensus Panel Report from the Radioembolization Brachytherapy Oncology Consortium","year":2007,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":676,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Brachytherapy; Microsphere; Selective internal radiation therapy; Medical physics; Context (archaeology); Radiation therapy; Radiation treatment planning; Surgical oncology; Radiology; Nuclear medicine; Oncology; Internal medicine; Hepatocellular carcinoma","retraction":null,"screen_n_in":null,"score":{"opus":0.09712786714004835,"gpt":0.3617208968930969,"spread":0.2645930297530485,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001419847,0.0002866377,0.0008372042,0.0001741044,0.0001771646,0.0000310554,0.0002875245,0.0003996766,0.0001085395],"category_scores_gemma":[0.0006511544,0.0002321001,0.0004292453,0.0003166609,0.0003157833,0.0001852016,0.00003050993,0.0003302139,0.00000378493],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009033351,"about_ca_system_score_gemma":0.00124431,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001516557,"about_ca_topic_score_gemma":0.00003667006,"domain_scores_codex":[0.996915,0.0003905808,0.00175523,0.0003186353,0.0003046651,0.00031587],"domain_scores_gemma":[0.9928045,0.002022762,0.0028761,0.0002655204,0.001896953,0.0001341302],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001812108,0.0008523498,0.8031621,0.00001997879,0.001810392,0.0001481485,0.001783531,0.0001951564,0.06469861,0.002361164,0.001841217,0.1213152],"study_design_scores_gemma":[0.06877823,0.01042183,0.2189963,0.0008826253,0.005253513,0.009032568,0.003181597,0.06834015,0.2086961,0.03041809,0.3742855,0.001713445],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8274071,0.00207486,0.1615242,0.005458851,0.0022484,0.0009145261,0.000205038,0.00003468672,0.000132327],"genre_scores_gemma":[0.9694979,0.001097479,0.02483949,0.00138802,0.002119486,0.00002615007,0.0009314339,0.0000527043,0.00004736118],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5841658,"threshold_uncertainty_score":0.9464766,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2969846817","doi":"10.1111/liv.14223","title":"Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma","year":2019,"lang":"en","type":"review","venue":"Liver International","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":592,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital","funders":"Cancer Research UK; Eli Lilly and Company","keywords":"Hepatocellular carcinoma; Biomarker; Clinical significance; Alpha-fetoprotein; Medicine; Disease; Cancer; Stage (stratigraphy); Angiogenesis; Oncology; Biomarker discovery; Internal medicine; Bioinformatics; Cancer research; Biology; Proteomics; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.1258064352287268,"gpt":0.3291225500715129,"spread":0.2033161148427861,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001561721,0.0002767366,0.001164375,0.0003752357,0.00001038541,0.000008819341,0.0001716796,0.0002859143,0.0004120248],"category_scores_gemma":[0.00002934686,0.000227418,0.0002916295,0.0001228091,0.0000865292,0.00004289076,0.00009386474,0.0002495993,0.00009486089],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001274822,"about_ca_system_score_gemma":0.0002052139,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002985781,"about_ca_topic_score_gemma":0.000005208751,"domain_scores_codex":[0.9986069,0.00009667323,0.000520775,0.0004191686,0.0001815308,0.0001749881],"domain_scores_gemma":[0.9992515,0.0001224938,0.0002452751,0.000240245,0.00007513284,0.00006530443],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003967699,0.0001587685,0.5163893,0.007945511,0.0003554514,0.000316062,0.0000668107,1.398516e-8,0.00003300446,0.001359163,0.00005425255,0.473282],"study_design_scores_gemma":[0.001141424,0.0003000592,0.003492629,0.00495047,0.0007833121,0.0001423874,0.000008105815,0.0006648076,0.0001888215,0.00007224386,0.9879477,0.000308066],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01237538,0.9841364,0.00002087441,0.00003808625,0.000226801,0.001395917,0.0001192094,0.00000999776,0.001677312],"genre_scores_gemma":[0.1246367,0.8732811,0.0002727684,0.00002148741,0.0001301406,0.0001511868,0.0004785459,0.00002939626,0.0009987217],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9878934,"threshold_uncertainty_score":0.9273836,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2008655007","doi":"10.1002/lt.22365","title":"Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence-based analysis of 15 years of experience","year":2011,"lang":"en","type":"review","venue":"Liver Transplantation","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":582,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Cancer Institute; Associazione Italiana per la Ricerca sul Cancro","keywords":"Medicine; Hepatocellular carcinoma; Milan criteria; Liver transplantation; Cirrhosis; Transplantation; Cancer; Incidence (geometry); Liver cancer; Cohort; Intensive care medicine; Internal medicine; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.1820185482559223,"gpt":0.3372171954968544,"spread":0.1551986472409321,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003431189,0.0004019671,0.001875198,0.001285037,0.00003005267,0.00001153251,0.0002000586,0.0003805195,0.000191011],"category_scores_gemma":[0.00001538456,0.0003883834,0.0009430543,0.001023943,0.0001005804,0.0002828584,0.000003969802,0.0001484286,0.000003935228],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008478916,"about_ca_system_score_gemma":0.0002485185,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001463897,"about_ca_topic_score_gemma":0.0002237315,"domain_scores_codex":[0.9974342,0.0003219911,0.001065244,0.0005842981,0.0003206981,0.0002735428],"domain_scores_gemma":[0.9984571,0.0003862813,0.0004620073,0.0004066698,0.0001619819,0.0001259345],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.003725736,0.001540362,0.3313282,0.2610333,0.00244345,0.002999612,0.03456417,0.000008493703,0.0006872923,0.0001296183,0.000006510484,0.3615332],"study_design_scores_gemma":[0.01264733,0.006910431,0.4206156,0.1007045,0.371422,0.0003601009,0.0005596407,0.05216823,0.02293584,0.00002657134,0.008334341,0.003315442],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.3546465,0.6405655,0.002065179,0.000001937692,0.00005958239,0.001920388,0.0006977929,0.00002062799,0.00002248202],"genre_scores_gemma":[0.4236782,0.5712392,0.001173005,0.000007693734,0.00002087301,0.0002682792,0.003574575,0.00003021907,0.000007938915],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3689786,"threshold_uncertainty_score":0.9998568,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2039553081","doi":"10.1016/j.jvir.2014.08.027","title":"Image-Guided Tumor Ablation: Standardization of Terminology and Reporting Criteria—A 10-Year Update","year":2014,"lang":"en","type":"article","venue":"Journal of Vascular and Interventional Radiology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":581,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Terminology; Cryoablation; Medical physics; Ablative case; Standardization; Modalities; Radiofrequency ablation; Microwave ablation; Ablation; Radiology; Computer science; Radiation therapy","retraction":null,"screen_n_in":null,"score":{"opus":0.05775989046697499,"gpt":0.3210463314177438,"spread":0.2632864409507688,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001276323,0.0000901296,0.0004903919,0.0001625447,0.00003710638,0.00001149001,0.00003357201,0.00006482907,0.0004053581],"category_scores_gemma":[0.0007197298,0.00007016789,0.0002773148,0.00004863122,0.0001171077,0.0001053007,0.00002512498,0.00009360688,0.000001459483],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002132,"about_ca_system_score_gemma":0.00003921036,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003925547,"about_ca_topic_score_gemma":6.299477e-7,"domain_scores_codex":[0.9984338,0.0001806091,0.001028448,0.0001212692,0.0001366535,0.00009925811],"domain_scores_gemma":[0.9984597,0.00005236013,0.0009996847,0.00008921534,0.0003250345,0.0000740053],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006511639,0.0002612168,0.9626974,0.0005362037,0.001259827,0.0002803619,0.0001535721,0.000004713344,0.02069125,0.002449743,0.003614257,0.007400312],"study_design_scores_gemma":[0.01079854,0.007671976,0.9032359,0.0008225603,0.001620082,0.02297811,0.0001361752,0.006331834,0.01294777,0.005118136,0.02802951,0.0003094276],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9809768,0.001740842,0.01619239,0.0005484927,0.0001098825,0.00009228231,0.000004461539,0.000004571232,0.0003302458],"genre_scores_gemma":[0.9922396,0.0001659137,0.007285378,0.00005806561,0.0001716457,0.000001991992,0.00002683144,0.000008190962,0.00004236111],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05946149,"threshold_uncertainty_score":0.4438387,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4211037511","doi":"10.1038/s41572-021-00261-6","title":"Liver metastases","year":2021,"lang":"en","type":"review","venue":"Nature Reviews Disease Primers","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":565,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Metastasis; Colorectal cancer; Pancreas; Pancreatic cancer; Cancer; Liver transplantation; Pathology; Oncology; Cancer research; Internal medicine; Transplantation","retraction":null,"screen_n_in":null,"score":{"opus":0.136087620323244,"gpt":0.3706732147135502,"spread":0.2345855943903062,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0004366716,0.0009269936,0.004772263,0.0002643814,0.00008656096,0.00005429268,0.0002378372,0.0007197036,0.001694248],"category_scores_gemma":[0.0005648244,0.000610134,0.004581103,0.000819077,0.00007021075,0.00007644945,0.0001259446,0.001400011,0.001043843],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002538241,"about_ca_system_score_gemma":0.001352792,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003476446,"about_ca_topic_score_gemma":5.2861e-7,"domain_scores_codex":[0.9963846,0.0008073915,0.0009018287,0.0009572884,0.0004902781,0.0004586487],"domain_scores_gemma":[0.9971244,0.0001592042,0.0004420813,0.001200543,0.0001292908,0.0009444851],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001008991,0.0002382204,0.0001311304,0.06380525,0.0009589957,0.002178904,0.000004197613,8.645892e-10,4.553335e-8,0.00009895844,0.0191518,0.9134224],"study_design_scores_gemma":[0.0002397778,0.00003471097,0.000009888926,0.04718047,0.03822972,0.0001035277,0.000001265783,0.000001122672,0.000001233433,0.00000175027,0.9137343,0.0004622029],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[7.744433e-7,0.9942324,0.000004057976,0.00007774613,0.000308245,0.004095237,0.0002092405,0.00008637091,0.0009859026],"genre_scores_gemma":[0.000003705808,0.9905915,0.001351879,0.0005565431,0.00044816,0.0007007219,0.004848954,0.0001276569,0.001370897],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9129602,"threshold_uncertainty_score":0.999734,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1980305246","doi":"10.1055/s-0032-1325499","title":"Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver – Update 2012","year":2012,"lang":"en","type":"article","venue":"Ultraschall in der Medizin - European Journal of Ultrasound","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":551,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Contrast-enhanced ultrasound; Ultrasound; Medicine; Medical physics; Contrast (vision); Radiology; Ultrasound imaging; Computer science; Artificial intelligence","retraction":null,"screen_n_in":null,"score":{"opus":0.1695474614471095,"gpt":0.3767513234611428,"spread":0.2072038620140333,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01162834,0.0003533735,0.0006928202,0.0002686849,0.0001228218,0.00009517976,0.0003233803,0.0001241181,0.0001565423],"category_scores_gemma":[0.009030675,0.0002431907,0.0002866298,0.0003171336,0.0002094686,0.0009537517,0.00002625148,0.0008652962,0.00004045046],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007252995,"about_ca_system_score_gemma":0.0001185014,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001788163,"about_ca_topic_score_gemma":0.00004167344,"domain_scores_codex":[0.9947459,0.001822525,0.001995851,0.0003154048,0.0005008016,0.0006195094],"domain_scores_gemma":[0.9897712,0.008115039,0.0007923625,0.0003470489,0.0005759373,0.0003983458],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00306023,0.007202901,0.7705675,0.0002876647,0.001747711,0.001190544,0.01838585,0.00000515758,0.01610276,0.001523673,0.07258467,0.1073414],"study_design_scores_gemma":[0.01618404,0.002549734,0.265918,0.0008527241,0.002054357,0.01034086,0.0093021,0.00003524356,0.002290863,0.000195901,0.6895602,0.0007159626],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.93304,0.03175921,0.00560605,0.02154367,0.001258636,0.001652409,0.00004963258,0.00002925814,0.005061176],"genre_scores_gemma":[0.944338,0.01796095,0.03229512,0.003633761,0.001525873,0.00002236967,0.00006319545,0.00006544145,0.00009532534],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6169755,"threshold_uncertainty_score":0.9993167,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2154143304","doi":"10.1200/jco.2006.05.8156","title":"Liver Histology and Surgical Outcomes After Preoperative Chemotherapy With Fluorouracil Plus Oxaliplatin in Colorectal Cancer Liver Metastases","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":512,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Saint-Luc","funders":"","keywords":"Medicine; Oxaliplatin; Chemotherapy; Colorectal cancer; Perioperative; Steatosis; Internal medicine; Fluorouracil; Gastroenterology; Surgery; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.09593084241687191,"gpt":0.3804911437631749,"spread":0.2845603013463031,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001001654,0.0002061139,0.001707754,0.0001333122,0.0000288437,0.00000944915,0.00006304311,0.0003329313,0.0006045224],"category_scores_gemma":[0.0001775964,0.0001204291,0.0002756701,0.0001129152,0.0003444537,0.0001202981,0.00002708967,0.0006101407,0.000006269037],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000255503,"about_ca_system_score_gemma":0.0009038806,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005632758,"about_ca_topic_score_gemma":0.002091698,"domain_scores_codex":[0.9974443,0.0005531675,0.00127082,0.0002366875,0.0002467274,0.0002482684],"domain_scores_gemma":[0.9972633,0.001636004,0.0005898732,0.00007940578,0.000229442,0.0002020122],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01311443,0.001078552,0.9496619,0.00002066064,0.0003834437,0.0140284,0.0002473572,0.000003938683,0.0000210823,0.00004134936,0.0004372238,0.02096166],"study_design_scores_gemma":[0.01766337,0.007655574,0.9600996,0.00006169827,0.0005482862,0.001328798,0.00004832305,0.000384884,0.0002558591,0.00002259418,0.01179519,0.0001358644],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9893966,0.005763544,0.00001580567,0.003697602,0.0001584147,0.0003421386,0.000008801288,0.000007260894,0.0006097783],"genre_scores_gemma":[0.9941725,0.001409997,0.002891799,0.0006962568,0.0003751464,0.0000357762,0.000004942772,0.00001783889,0.0003957963],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0208258,"threshold_uncertainty_score":0.6619096,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2136977965","doi":"10.1200/jco.2007.15.9947","title":"Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":510,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Research Resources; U.S. Department of Health and Human Services; National Institutes of Health; National Cancer Institute; Genentech; American Society of Clinical Oncology","keywords":"Medicine; Bevacizumab; Hepatocellular carcinoma; Internal medicine; Vascular endothelial growth factor; Gastroenterology; Angiogenesis; Oncology; Adverse effect; Phases of clinical research; Clinical trial; Chemotherapy; VEGF receptors","retraction":null,"screen_n_in":null,"score":{"opus":0.4016800966902733,"gpt":0.4960715878263401,"spread":0.09439149113606682,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01010604,0.0001986946,0.002309827,0.0001639845,0.0001194696,0.000004371761,0.0002013064,0.0005821028,0.00004982854],"category_scores_gemma":[0.01280371,0.0001113013,0.0007920848,0.0002577998,0.000741004,0.00008037224,0.0001269421,0.001275356,0.000004058965],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006531567,"about_ca_system_score_gemma":0.001856186,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004807187,"about_ca_topic_score_gemma":0.000008579749,"domain_scores_codex":[0.9925362,0.002671067,0.003768071,0.000285773,0.0004265958,0.000312241],"domain_scores_gemma":[0.9881065,0.009186596,0.001772338,0.000283536,0.0003270813,0.0003239289],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.08437687,0.007767074,0.8354099,0.00005293622,0.0002628545,0.002748214,0.000198561,2.874822e-7,0.0004573399,0.00002173328,0.0002493968,0.06845483],"study_design_scores_gemma":[0.3689402,0.4182696,0.203093,0.0001610559,0.001061898,0.0008910018,0.00007255894,0.00359278,0.001095523,0.0003475517,0.002320949,0.0001538886],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918563,0.004062396,0.00001852819,0.001603264,0.001083479,0.001076264,0.000001666317,0.000006355504,0.0002917293],"genre_scores_gemma":[0.9956685,0.001551639,0.001166252,0.0003813458,0.001091401,0.00001950088,0.000003254324,0.00001558457,0.0001024742],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6323169,"threshold_uncertainty_score":0.9955118,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3045236009","doi":"10.1016/j.ultrasmedbio.2020.04.030","title":"Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver–Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS","year":2020,"lang":"en","type":"article","venue":"Ultrasound in Medicine & Biology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":490,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Contrast-enhanced ultrasound; Contrast (vision); Guideline; Medicine; Medical physics; Ultrasound; Food and drug administration; Protocol (science); Computer science; Radiology; Pathology; Risk analysis (engineering); Alternative medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1419958069068641,"gpt":0.3865278569233653,"spread":0.2445320500165013,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001877771,0.0002750041,0.0007260309,0.0001129587,0.00008468374,0.00002633517,0.0001162633,0.0002126162,0.00008237845],"category_scores_gemma":[0.009362779,0.0001728128,0.00004055,0.000457521,0.0003835175,0.0001660968,0.00002137778,0.000522934,0.000005314444],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004064682,"about_ca_system_score_gemma":0.0001203039,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004560498,"about_ca_topic_score_gemma":0.001780402,"domain_scores_codex":[0.997345,0.000593356,0.0009809943,0.0005991064,0.000133901,0.0003476774],"domain_scores_gemma":[0.9932839,0.005931175,0.0001980693,0.0002072469,0.0002200871,0.0001595671],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002470839,0.0005224333,0.9242606,0.0001465096,0.0001644309,0.0001380374,0.005022042,0.000002168843,0.009975108,0.0008940771,0.004749526,0.05165419],"study_design_scores_gemma":[0.06822211,0.02718344,0.3690552,0.001554044,0.001912094,0.001876437,0.01745571,0.005114891,0.001281717,0.0007268912,0.5042232,0.001394373],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8878354,0.005043352,0.001829699,0.1022368,0.0001422539,0.002193678,0.00004439104,0.00002948936,0.0006449055],"genre_scores_gemma":[0.9601681,0.0179302,0.006175373,0.01432581,0.0004678853,0.0002301586,0.0006605441,0.00002235241,0.00001954274],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5552055,"threshold_uncertainty_score":0.9989818,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2008979634","doi":"10.1002/hep.27304","title":"LI‐RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI‐RADS Management Working Group and future directions","year":2014,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":486,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"American Association for the Study of Liver Diseases","keywords":"Medicine; Hepatocellular carcinoma; Radiology; Guideline; Magnetic resonance imaging; Medical physics; Internal medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.04943632932345485,"gpt":0.2629220920104401,"spread":0.2134857626869852,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005836179,0.0001687979,0.0004181405,0.00008984333,0.0002382666,0.00002264356,0.00008285107,0.00008803435,0.000004722016],"category_scores_gemma":[0.00007501536,0.00009632747,0.00004400603,0.0001366037,0.0002184952,0.0000399959,0.0003940734,0.000148121,5.985458e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002415446,"about_ca_system_score_gemma":0.00001569383,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001870289,"about_ca_topic_score_gemma":0.000105681,"domain_scores_codex":[0.9984909,0.0002023632,0.0005002149,0.0004581631,0.000126101,0.0002223171],"domain_scores_gemma":[0.9988344,0.00008580287,0.0003635599,0.0005859543,0.00002786403,0.0001023652],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00003503738,0.0000306452,0.9292772,0.0004296653,0.000101783,0.0002124879,0.0002149668,8.85718e-9,0.000062752,0.001325301,0.0004320976,0.06787807],"study_design_scores_gemma":[0.002964757,0.0001790925,0.6977701,0.001655674,0.002152686,0.005928383,0.001970436,0.07544259,0.0001975626,0.0001858301,0.2111263,0.0004265366],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9734243,0.01650278,0.0001336297,0.006260424,0.0004727582,0.0006215957,0.000009496202,0.00007381078,0.002501173],"genre_scores_gemma":[0.9976838,0.001204042,0.0006508035,0.0001141909,0.0001604735,0.00001941421,0.00002801886,0.00001898474,0.0001202561],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2315071,"threshold_uncertainty_score":0.392812,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2113248775","doi":"10.1200/jco.2008.20.0600","title":"Phase I Study of Individualized Stereotactic Body Radiotherapy of Liver Metastases","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":477,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Radiation therapy; Radiosurgery; Radiology; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.2759012252756107,"gpt":0.4897182574946933,"spread":0.2138170322190826,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002737941,0.0001371269,0.002160596,0.0002147179,0.00001734552,0.000003639826,0.0001396856,0.0001860081,0.0003254737],"category_scores_gemma":[0.0009964339,0.00009016401,0.0006139547,0.0001751467,0.0001020656,0.0000926178,0.00001426685,0.0004159112,0.000002190378],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004731907,"about_ca_system_score_gemma":0.0005599004,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002342404,"about_ca_topic_score_gemma":0.000004312296,"domain_scores_codex":[0.9957279,0.0009712505,0.00258532,0.0001359982,0.0004296685,0.0001498727],"domain_scores_gemma":[0.9952061,0.001587243,0.002376497,0.0002127757,0.0003744957,0.0002429002],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01591036,0.07744146,0.6163545,0.00003754389,0.003232758,0.002716197,0.0009737557,4.127335e-7,0.001855257,0.00003188941,0.0008744042,0.2805715],"study_design_scores_gemma":[0.1155738,0.4175036,0.445454,0.0001095798,0.005225367,0.0004343544,0.0003972881,0.0001417546,0.002598077,0.00009382486,0.01233373,0.0001346017],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959257,0.002156872,0.00004463154,0.0008021597,0.0002119564,0.0004376291,0.000005778631,0.00000459205,0.0004106662],"genre_scores_gemma":[0.9953993,0.0008266,0.002934802,0.0004761281,0.0002976529,0.000001848884,0.000002859423,0.000009849982,0.00005096262],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3400621,"threshold_uncertainty_score":0.3676782,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2139080209","doi":"10.1148/radiol.10091210","title":"Microbubble-enhanced US in Body Imaging: What Role?<sup/>","year":2010,"lang":"en","type":"review","venue":"Radiology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":461,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Radiology; Magnetic resonance imaging; Vascularity; Microbubbles; Hepatocellular carcinoma; Ultrasound; Renal cell carcinoma; Pathology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04459878208443868,"gpt":0.3005752728393621,"spread":0.2559764907549234,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003072884,0.0005973467,0.002838144,0.0004811941,0.00004257721,0.00004284843,0.0002454703,0.0008880464,0.0003346129],"category_scores_gemma":[0.00006755193,0.000465709,0.0006714137,0.0003081088,0.0001513379,0.000116393,0.00007452801,0.001158176,0.000537696],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002156928,"about_ca_system_score_gemma":0.0004195153,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003411741,"about_ca_topic_score_gemma":0.00001518085,"domain_scores_codex":[0.9974731,0.0003231669,0.0007120665,0.0007405099,0.0001124352,0.0006387794],"domain_scores_gemma":[0.9986213,0.0002044991,0.0002287689,0.0006933917,0.0000480332,0.0002040064],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003853623,0.0001291332,0.00917403,0.002516175,0.0001810602,0.0009003007,0.00008463758,2.332787e-8,0.0001634505,0.0000227102,0.0003790779,0.9864109],"study_design_scores_gemma":[0.000990284,0.0001730158,0.0001042149,0.004487124,0.001156974,0.002046832,0.00001930471,0.00003698048,0.0001005979,0.00002587304,0.9904901,0.0003687174],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003676499,0.9922296,0.000008199159,0.0001692021,0.0006068283,0.001445307,0.00001286705,0.00007501398,0.001776414],"genre_scores_gemma":[0.002457712,0.9945905,0.0002779823,0.000215125,0.0005298492,0.0003459576,0.0008480389,0.00009901349,0.000635822],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.990111,"threshold_uncertainty_score":0.9997795,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2055860546","doi":"10.1097/sla.0000000000000947","title":"Early Survival and Safety of ALPPS","year":2014,"lang":"en","type":"article","venue":"Annals of Surgery","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":457,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Universitätsspital Zürich; Universität Zürich","keywords":"Medicine; MEDLINE; Intensive care medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.3153375861896928,"gpt":0.306777067262279,"spread":0.00856051892741383,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006049992,0.00007698627,0.0003952123,0.00009124204,0.00001584247,0.000002559252,0.00002037928,0.00005227515,0.00006139873],"category_scores_gemma":[0.0001354417,0.00006332503,0.0001451144,0.00009555404,0.00006925723,0.00004151508,0.00001598447,0.00003916912,0.000006283803],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000001487004,"about_ca_system_score_gemma":0.00002715425,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001137651,"about_ca_topic_score_gemma":0.00000137073,"domain_scores_codex":[0.9992976,0.00005723759,0.0002571626,0.0001064347,0.0001524104,0.0001291344],"domain_scores_gemma":[0.9991421,0.0004157468,0.00008881685,0.0001561455,0.0001108447,0.00008631989],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001882728,0.00007118646,0.9732265,0.0001145888,0.00008443794,0.000008775199,0.00005944259,2.263363e-8,0.0008369637,0.0002807268,0.0007721693,0.02435693],"study_design_scores_gemma":[0.0002841614,0.0001388417,0.9626911,0.0001201761,0.00005082275,0.000004162434,0.00001694385,0.00003154684,0.03160505,0.0001294224,0.004862745,0.00006506677],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937928,0.0008165271,0.00001869838,0.0009961027,0.00005956743,0.00008062352,0.000008589762,0.00001111044,0.004215955],"genre_scores_gemma":[0.9990526,0.0005546904,0.00005562274,0.00009194937,0.0000517741,0.000002519067,0.00001458585,0.000009445711,0.000166844],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03076809,"threshold_uncertainty_score":0.258232,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2024885453","doi":"10.1111/j.1477-2574.2011.00319.x","title":"Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS)","year":2011,"lang":"en","type":"review","venue":"HPB","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":452,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Laparotomy; Grading (engineering); Hepatectomy; Embolization; Blood loss; Radiological weapon; Surgery; Packed red blood cells; Blood transfusion; Radiology; General surgery; Resection","retraction":null,"screen_n_in":null,"score":{"opus":0.2438105863549838,"gpt":0.2953219300105592,"spread":0.05151134365557536,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004031697,0.0002661094,0.0009353363,0.0001869584,0.00005724574,0.00002300465,0.0001134013,0.0001302699,0.0004660819],"category_scores_gemma":[0.00006353037,0.0001626579,0.0003687399,0.000140112,0.00005514729,0.00005439324,0.00007501593,0.0002106184,0.00008556249],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000527149,"about_ca_system_score_gemma":0.00006759377,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003636568,"about_ca_topic_score_gemma":0.00001698403,"domain_scores_codex":[0.9987611,0.0001697397,0.0004220697,0.0002819077,0.0002139894,0.0001512084],"domain_scores_gemma":[0.9990104,0.0003395107,0.0002558496,0.0002497728,0.0000765399,0.00006795822],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003407468,0.0004702438,0.04735025,0.003208179,0.00066539,0.0001927563,0.0003858451,1.34273e-10,0.000003227438,0.00002207687,0.001626489,0.9460415],"study_design_scores_gemma":[0.001403194,0.0009741192,0.004297281,0.008535531,0.009554222,0.001036529,0.000237708,0.00006801113,0.0000170344,0.00001377909,0.9732541,0.000608518],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02825833,0.9694691,0.00001550186,0.00001148845,0.000179246,0.001276292,0.00008729255,0.00002265075,0.0006801442],"genre_scores_gemma":[0.031303,0.9672285,0.0001293154,0.00003866748,0.0001018405,0.0002272622,0.0006055965,0.00004027763,0.0003255075],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9716276,"threshold_uncertainty_score":0.6632997,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2570611720","doi":"10.1038/nrgastro.2016.193","title":"Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches","year":2017,"lang":"en","type":"review","venue":"Nature Reviews Gastroenterology & Hepatology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":435,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto","funders":"Instituto de Salud Carlos III; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas","keywords":"Medicine; Hepatocellular carcinoma; Liver transplantation; Transplantation; Donation; Milan criteria; Intensive care medicine; Population; Surgery; Carcinoma; Internal medicine; General surgery; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.2041502882159887,"gpt":0.3506759577320902,"spread":0.1465256695161015,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.000935952,0.001303359,0.007905581,0.0004654387,0.0002896691,0.00004633057,0.0004503463,0.002828315,0.00004080447],"category_scores_gemma":[0.0001589982,0.0009110071,0.002430521,0.0001061787,0.0004541655,0.0001095739,0.0001250683,0.001781373,0.00004039676],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001481063,"about_ca_system_score_gemma":0.0002316505,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001974969,"about_ca_topic_score_gemma":0.00004330864,"domain_scores_codex":[0.9950218,0.0006610153,0.001567744,0.001516227,0.0002263388,0.001006865],"domain_scores_gemma":[0.996816,0.0004193879,0.001163286,0.001103356,0.000108571,0.0003894057],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000380911,0.0003534779,0.4352194,0.0521024,0.0009299656,0.00211533,0.00003384706,1.830601e-9,2.54838e-7,0.000405638,0.0004116986,0.508047],"study_design_scores_gemma":[0.003424726,0.0009186742,0.0009907432,0.002746005,0.01321005,0.01550468,0.000001450548,0.0001998734,0.000001316644,0.00001170324,0.9625884,0.0004023909],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002857779,0.988232,0.0004149762,0.0005074214,0.0005009855,0.006977057,0.0003097524,0.00006834824,0.0001316855],"genre_scores_gemma":[0.006990124,0.9845866,0.002444322,0.0003255691,0.0003445139,0.002340967,0.002586031,0.0001408627,0.0002410415],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9621767,"threshold_uncertainty_score":0.9999718,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1977756844","doi":"10.1016/j.surg.2006.06.028","title":"Recurrence after liver resection for hepatocellular carcinoma: Risk factors, treatment, and outcomes","year":2006,"lang":"en","type":"article","venue":"Surgery","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":422,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Proportional hazards model; Perioperative; Univariate analysis; Multivariate analysis; Surgery; Internal medicine; Survival analysis; Hepatectomy; Liver transplantation; Cohort; Stage (stratigraphy); Liver cancer; Gastroenterology; Transplantation; Resection","retraction":null,"screen_n_in":null,"score":{"opus":0.07692021191496848,"gpt":0.2500896890514258,"spread":0.1731694771364573,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000186906,0.0002633879,0.0004655379,0.0001833975,0.000133462,0.00003129175,0.0000217792,0.0001273635,0.00007025429],"category_scores_gemma":[0.00007661043,0.0001923806,0.0003558908,0.0001315318,0.00005815261,0.0001032605,0.00001438733,0.0000750398,0.00001479313],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001136101,"about_ca_system_score_gemma":0.00006732789,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00204753,"about_ca_topic_score_gemma":0.0001214449,"domain_scores_codex":[0.9988129,0.0000735667,0.0002742897,0.0003833458,0.0001291224,0.0003267656],"domain_scores_gemma":[0.9989287,0.0005292568,0.00009721838,0.0002509087,0.00007032198,0.0001235486],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003642605,0.0002095261,0.9948362,0.0000741581,0.00008706789,0.0001169707,0.00008575604,4.138064e-8,0.00005805766,0.00001278988,0.0008503217,0.003304826],"study_design_scores_gemma":[0.0008623166,0.000372858,0.982555,0.00003200962,0.0004118588,0.00001685935,0.00002130866,0.000504917,0.007638631,0.0001065596,0.007277084,0.0002006269],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937145,0.004733778,0.00007469086,0.0001131885,0.0002335943,0.0007787793,0.0001222646,0.00006649338,0.0001626938],"genre_scores_gemma":[0.9972095,0.0004647101,0.0001914376,0.00002191548,0.000185329,0.0002975844,0.0003059502,0.00003370296,0.001289893],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01228125,"threshold_uncertainty_score":0.7845052,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2143637070","doi":"10.1002/hep.27745","title":"The role of hepatic resection in the treatment of hepatocellular cancer","year":2015,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":415,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Hepatocellular cancer; Medicine; Resection; Hepatocellular carcinoma; Cancer; Internal medicine; Gastroenterology; Oncology; General surgery; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.08014583123517036,"gpt":0.2949904154635464,"spread":0.214844584228376,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003192136,0.0001310948,0.0003726441,0.00009131515,0.00004668169,0.00000422895,0.0001038049,0.0001021264,0.00002281574],"category_scores_gemma":[0.00004978136,0.00006729877,0.0001291689,0.0002856826,0.0001571626,0.00002326255,0.000011723,0.00007438697,0.000009151398],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001320576,"about_ca_system_score_gemma":0.0002049776,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004456714,"about_ca_topic_score_gemma":0.001718056,"domain_scores_codex":[0.9987567,0.0002757864,0.0003586406,0.000160764,0.0002226333,0.0002254793],"domain_scores_gemma":[0.999095,0.0002151264,0.0001309563,0.0003804742,0.0001175291,0.00006087242],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004441103,0.0004728182,0.9843035,0.00002196339,0.00009104301,0.00005878793,0.002388624,5.121846e-7,0.0007468019,0.0006025134,0.00008939768,0.01077992],"study_design_scores_gemma":[0.0155763,0.02039114,0.1537172,0.0002316889,0.001770165,0.0005239978,0.008618068,0.09841526,0.421007,0.01011311,0.2690597,0.0005763603],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9787899,0.01779523,0.000004538613,0.001022932,0.000119925,0.0006808295,0.000005525453,0.0000102062,0.001570865],"genre_scores_gemma":[0.9972226,0.002231345,0.00004551284,0.00003874355,0.00005309145,0.000275065,0.00001446443,0.00001212192,0.0001070557],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8305863,"threshold_uncertainty_score":0.6737248,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2034320803","doi":"10.1055/s-0030-1247128","title":"Hepatocellular Carcinoma: Epidemiology, Surveillance, and Diagnosis","year":2010,"lang":"en","type":"review","venue":"Seminars in Liver Disease","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":398,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"","keywords":"Hepatocellular carcinoma; Medicine; Cirrhosis; Incidence (geometry); HCCS; Epidemiology; Carcinoma; Internal medicine; Gastroenterology; Intensive care medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.09723845612733516,"gpt":0.3181171327071317,"spread":0.2208786765797965,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008823718,0.0008308916,0.0030944,0.0005042575,0.00009377828,0.00002114393,0.0002269742,0.0007650543,0.0002348864],"category_scores_gemma":[0.0007382696,0.0006793946,0.0008648189,0.0004465942,0.0003599485,0.00007726171,0.0002150567,0.001020858,0.0001292564],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001869969,"about_ca_system_score_gemma":0.0004664776,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001565101,"about_ca_topic_score_gemma":0.00001380046,"domain_scores_codex":[0.9963322,0.0006563196,0.0009282228,0.001134852,0.0002308864,0.0007175659],"domain_scores_gemma":[0.9965081,0.001359048,0.000317879,0.0009368574,0.00006066086,0.0008174556],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003065691,0.000189407,0.5770684,0.008833492,0.00006826379,0.002681804,0.00002026889,3.950536e-9,2.900244e-8,0.00003457309,0.0005938586,0.4104792],"study_design_scores_gemma":[0.0006791553,0.0001364691,0.05433539,0.01058923,0.002554239,0.0001456842,0.000005277098,0.0001678477,6.067419e-7,0.00007459065,0.9306909,0.0006206022],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02133578,0.9751524,0.000001529542,0.0001329688,0.0002664317,0.0024326,0.0002970312,0.00007253039,0.0003087005],"genre_scores_gemma":[0.02218731,0.9740631,0.0003106366,0.00012472,0.0002419372,0.001380654,0.001119713,0.0001205734,0.0004513614],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.930097,"threshold_uncertainty_score":0.9995657,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2010129875","doi":"10.1245/aso.2006.05.039","title":"Survival After Hepatic Resection for Colorectal Metastases: A 10-Year Experience","year":2006,"lang":"en","type":"article","venue":"Annals of Surgical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":379,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mount Sinai Hospital; University of Toronto; University Health Network","funders":"","keywords":"Surgical oncology; Medicine; Resection; General surgery; Colorectal cancer; Colorectal surgery; Hepatectomy; Oncology; Internal medicine; Surgery; Abdominal surgery; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.11505480094736,"gpt":0.3611885590715403,"spread":0.2461337581241804,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003848761,0.0001361524,0.0005145503,0.00009996989,0.00004274676,0.000006627507,0.00005154953,0.0001582829,0.0009427515],"category_scores_gemma":[0.00004193202,0.0001081814,0.0002900541,0.0001850869,0.0001540127,0.00006191281,0.00002632895,0.00007606473,0.000033542],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003591383,"about_ca_system_score_gemma":0.00009662366,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001603344,"about_ca_topic_score_gemma":0.00008588326,"domain_scores_codex":[0.9987366,0.0001446286,0.0003696515,0.0002531977,0.0001951287,0.0003008026],"domain_scores_gemma":[0.9989776,0.0004358952,0.0001013262,0.0001360691,0.0002378961,0.0001111952],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.05463281,0.004654656,0.8960685,0.0003788874,0.000568348,0.002761617,0.0006422431,0.000003112573,0.003621808,0.002837897,0.01534172,0.01848844],"study_design_scores_gemma":[0.006117134,0.01471164,0.02620471,0.00006089529,0.0002955596,0.0001388594,0.0002054505,0.0003624491,0.0667935,0.000583825,0.8842569,0.0002691055],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868857,0.0006231251,0.00003642599,0.002113656,0.000126958,0.0005722995,0.00004270421,0.00002866863,0.009570473],"genre_scores_gemma":[0.9974828,0.0002534955,0.0005659566,0.00008022296,0.0002199923,0.0004058132,0.0001055496,0.00001547725,0.0008707221],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8698637,"threshold_uncertainty_score":0.9999705,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3165241302","doi":"10.1016/s1470-2045(21)00151-0","title":"Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":373,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Roche (Canada)","funders":"Genentech; F. Hoffmann-La Roche","keywords":"Medicine; Sorafenib; Bevacizumab; Atezolizumab; Internal medicine; Oncology; Hepatocellular carcinoma; Quality of life (healthcare); Response Evaluation Criteria in Solid Tumors; Clinical trial; Progression-free survival; Performance status; Cancer; Clinical endpoint; Phases of clinical research; Surgery; Chemotherapy; Pembrolizumab; Immunotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.1298463038578968,"gpt":0.3448993800596667,"spread":0.2150530762017699,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006697583,0.0005045771,0.001924551,0.000148321,0.0002379541,0.0001107486,0.0004487748,0.0002572526,0.000345445],"category_scores_gemma":[0.0001964001,0.0002993363,0.00009320449,0.0006279012,0.0002074271,0.0002283157,0.0002452405,0.0005301072,0.0000272463],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006774478,"about_ca_system_score_gemma":0.001711356,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005230851,"about_ca_topic_score_gemma":0.0005911901,"domain_scores_codex":[0.99595,0.0009373649,0.0007636099,0.0008110915,0.0006409114,0.0008969601],"domain_scores_gemma":[0.9972141,0.0004290617,0.0004141251,0.001270662,0.000365201,0.0003068509],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5884247,0.004032014,0.3983309,0.00003552017,0.0005832186,0.003652835,0.0006168416,0.000003126167,0.00008200949,0.00006157302,0.000203584,0.003973698],"study_design_scores_gemma":[0.940531,0.03429028,0.01770782,0.00006726325,0.0009985297,0.00009794001,0.0002754611,0.0009671217,0.001560237,0.00003603178,0.003051104,0.0004172792],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887674,0.000322155,0.00001857796,0.001406646,0.0003970134,0.005677155,0.00004934317,0.0000832775,0.003278427],"genre_scores_gemma":[0.9961599,0.00003292434,0.000849097,0.0005137356,0.0002120583,0.0008168048,0.0009632483,0.00008471059,0.0003675857],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3806231,"threshold_uncertainty_score":0.9999459,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2372275742","doi":"10.1002/hep.28643","title":"The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study","year":2016,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":368,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Hepatocellular carcinoma; Liver transplantation; Medicine; Internal medicine; Prospective cohort study; Milan criteria; Transplantation; Oncology; Gastroenterology","retraction":null,"screen_n_in":null,"score":{"opus":0.03018370040149884,"gpt":0.2622580340583945,"spread":0.2320743336568957,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002253239,0.0001929283,0.0003042284,0.00005373894,0.0001317158,0.00001570642,0.0000729278,0.00009191769,0.00006209248],"category_scores_gemma":[0.00003644444,0.000100197,0.00006784387,0.00008714598,0.0000682293,0.0001541975,0.0000120433,0.00005084582,0.00001078697],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002778971,"about_ca_system_score_gemma":0.00008055728,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004363615,"about_ca_topic_score_gemma":0.001307513,"domain_scores_codex":[0.9986555,0.0001712785,0.0002859676,0.0003815891,0.0001861519,0.000319506],"domain_scores_gemma":[0.9991907,0.0001871256,0.00008441634,0.0002666216,0.0002002634,0.00007085239],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003905674,0.000811465,0.990176,0.00004472665,0.00008206964,0.0001514894,0.001084005,5.112476e-9,0.0001277572,0.0002095849,0.00003796244,0.003369242],"study_design_scores_gemma":[0.01318646,0.003590994,0.9786177,0.00003222339,0.0002917249,0.00002155858,0.0001534326,0.0005148479,0.003167088,0.0001081496,0.0001644006,0.0001513861],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945459,0.0002357165,0.0005421705,0.0002451482,0.0001031914,0.004108168,0.00002397451,0.00003804303,0.00015774],"genre_scores_gemma":[0.9982838,0.00006101013,0.0002173267,0.00003124526,0.00003989041,0.001143455,0.00006901036,0.00002898784,0.0001252543],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01155828,"threshold_uncertainty_score":0.4085914,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}